ProShare Advisors’s Molecular Templates, Inc. MTEM Stock Holding History

ProShare Advisors’s Portfolio MTEM Stock Details MTEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-851	Closed	-$44K	–	2224
2022 Q1	$44K	Sell	851 -216	-20%	-$9.54K	﹤0.01%	2121
2021 Q4	$63K	Buy	+1,067	New	+$79.9K	﹤0.01%	2258
2015 Q2	–	Sell	-69	Closed	-$46K	–	1806
2015 Q1	$46K	Buy	69 +1	+1%	+$658	﹤0.01%	1874
2014 Q4	$36K	Sell	68 -58	-46%	-$29K	﹤0.01%	1935
2014 Q3	$75K	Sell	126 -28	-18%	-$19.4K	﹤0.01%	2213
2014 Q2	$101K	Sell	154 -135	-47%	-$89.4K	﹤0.01%	2353
2014 Q1	$227K	Buy	+289	New	+$235K	﹤0.01%	2432
2013 Q4	–	Sell	-180	Closed	-$138K	–	1965
2013 Q3	$138K	Buy	180 +3	+2%	+$2.46K	﹤0.01%	2325
2013 Q2	$154K	Buy	+177	New	+$150K	﹤0.01%	2134

Other funds holding MTEM

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ProShare Advisors's MTEM Position: Q2 2022 in Review

ProShare Advisors sold out of Molecular Templates, Inc. (MTEM) in Q2 2022, closing a stake of 851 shares — an estimated $44K sold.

ProShare Advisors first reported a position in MTEM in Q2 2013 and held it in 9 quarters. The position peaked at $227K in Q1 2014. 65 funds tracked by Wall St. Rank hold MTEM as of Q2 2022.

ProShare Advisors reported no remaining Molecular Templates, Inc. position as of Q2 2022 after selling out during the quarter.
ProShare Advisors sold 851 Molecular Templates, Inc. shares in Q2 2022, an estimated $44K.
ProShare Advisors first reported a position in Molecular Templates, Inc. in Q2 2013 and held it in 9 quarters.
ProShare Advisors's Molecular Templates, Inc. position peaked at $227K in Q1 2014.
65 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q2 2022.

Based on ProShare Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.